{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T07:57:12Z","timestamp":1777103832297,"version":"3.51.4"},"reference-count":21,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T00:00:00Z","timestamp":1726790400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Asian Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.ajps.2024.100966","type":"journal-article","created":{"date-parts":[[2024,9,21]],"date-time":"2024-09-21T15:54:42Z","timestamp":1726934082000},"page":"100966","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Structure based release kinetics analysis of doxazosin mesylate sustained-release tablets using micro-computed tomography"],"prefix":"10.1016","volume":"19","author":[{"given":"Qian","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengqing","family":"Zan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanhan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenjing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingyun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guangchao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zunjian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiwen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianzhao","family":"Niu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingdi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajps.2024.100966_bib0001","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.sapharm.2019.01.013","article-title":"Communicating benefits and risks of generic drugs to consumers: patient and caregiver opinions of two FDA-developed educational materials","volume":"15","author":"Hohmann","year":"2019","journal-title":"Res Social Adm Pharm"},{"key":"10.1016\/j.ajps.2024.100966_bib0002","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jval.2021.06.014","article-title":"Do Cost-effectiveness analyses account for drug genericization? A literature review and assessment of implications","volume":"25","author":"Neumann","year":"2022","journal-title":"Value Health"},{"key":"10.1016\/j.ajps.2024.100966_bib0003","article-title":"The structural diversity of ibuprofen sustained-release pellets on the same goal of bioequivalence consistency","volume":"217","author":"Cao","year":"2022","journal-title":"Mater Design"},{"key":"10.1016\/j.ajps.2024.100966_bib0004","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ejpb.2009.07.002","article-title":"Oral osmotically driven systems: 30 years of development and clinical use","volume":"73","author":"Malaterre","year":"2009","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.ajps.2024.100966_bib0005","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.tibtech.2021.10.001","article-title":"Osmotic-controlled release oral tablets: technology and functional insights","volume":"40","author":"Ogueri","year":"2022","journal-title":"Trends Biotechnol"},{"key":"10.1016\/j.ajps.2024.100966_bib0006","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.ijpharm.2013.12.028","article-title":"Review of bilayer tablet technology","volume":"461","author":"Abebe","year":"2014","journal-title":"Int J Pharm"},{"key":"10.1016\/j.ajps.2024.100966_bib0007","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ijpharm.2012.02.017","article-title":"Microstructural investigation to the controlled release kinetics of monolith osmotic pump tablets via synchrotron radiation X-ray microtomography","volume":"427","author":"Li","year":"2012","journal-title":"Int J Pharm"},{"key":"10.1016\/j.ajps.2024.100966_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2020.105324","article-title":"Static and dynamic structural features of single pellets determine the release behaviors of metoprolol succinate sustained-release tablets","volume":"149","author":"Sun","year":"2020","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.ajps.2024.100966_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2020.111137","article-title":"Dynamic structure model of polyelectrolyte complex based controlled-release matrix tablets visualized by synchrotron radiation micro-computed tomography","volume":"116","author":"Yin","year":"2020","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"key":"10.1016\/j.ajps.2024.100966_bib0010","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1111\/jphp.12056","article-title":"Fractal structure determines controlled release kinetics of monolithic osmotic pump tablets","volume":"65","author":"Yin","year":"2013","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.ajps.2024.100966_bib0011","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1208\/s12248-013-9498-y","article-title":"Quantification of swelling and erosion in the controlled release of a poorly water-soluble drug using synchrotron X-ray computed microtomography","volume":"15","author":"Yin","year":"2013","journal-title":"AAPS J"},{"key":"10.1016\/j.ajps.2024.100966_bib0012","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1016\/j.apsb.2021.11.008","article-title":"Redefinition to bilayer osmotic pump tablets as subterranean river system within mini-earth via three-dimensional structure mechanism","volume":"12","author":"Maharjan","year":"2022","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.ajps.2024.100966_bib0013","doi-asserted-by":"crossref","first-page":"3606","DOI":"10.3390\/ma13163606","article-title":"A review of current challenges and case study toward optimizing micro-computed X-ray tomography of carbon fabric composites","volume":"13","author":"Rashidi","year":"2020","journal-title":"Materials (Basel)"},{"key":"10.1016\/j.ajps.2024.100966_bib0014","doi-asserted-by":"crossref","first-page":"R289","DOI":"10.1016\/j.cub.2017.01.066","article-title":"X-ray micro computed-tomography","volume":"27","author":"Baird","year":"2017","journal-title":"Curr Biol"},{"key":"10.1016\/j.ajps.2024.100966_bib0015","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.tifs.2015.10.016","article-title":"X-ray micro-computed tomography (\u00b5CT) for non-destructive characterisation of food microstructure","volume":"47","author":"Schoeman","year":"2016","journal-title":"Trends Food Sci Technol"},{"key":"10.1016\/j.ajps.2024.100966_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120834","article-title":"Discrimination of ranitidine hydrochloride crystals using X-ray micro-computed tomography for the evaluation of three-dimensional spatial distribution in solid dosage forms","volume":"605","author":"Yamamoto","year":"2021","journal-title":"Int J Pharm"},{"key":"10.1016\/j.ajps.2024.100966_bib0017","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ajps.2019.01.001","article-title":"Multi-dimensional visualization for the morphology of lubricant stearic acid particles and their distribution in tablets","volume":"15","author":"Zhang","year":"2020","journal-title":"Asian J Pharm Sci"},{"key":"10.1016\/j.ajps.2024.100966_bib0018","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ejps.2016.12.004","article-title":"Considerations for the development of in vitro dissolution tests to reduce or replace preclinical oral absorption studies","volume":"99","author":"Grignard","year":"2017","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.ajps.2024.100966_bib0019","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S1461-5347(98)00029-7","article-title":"Development of dissolution tests for oral extended-release products","volume":"1","author":"Jorgensen","year":"1998","journal-title":"Pharm Sci Tech Today"},{"key":"10.1016\/j.ajps.2024.100966_bib0020","article-title":"An overview of in vitro dissolution testing for film dosage forms","volume":"71","author":"Zhang","year":"2022","journal-title":"J Drug Deliv Sci Technol"},{"key":"10.1016\/j.ajps.2024.100966_bib0021","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.ejpb.2014.02.008","article-title":"The design of controlled-release formulations resistant to alcohol-induced dose dumping\u2013a review","volume":"87","author":"Jedinger","year":"2014","journal-title":"Eur J Pharm Biopharm"}],"container-title":["Asian Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1818087624000837?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1818087624000837?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T15:17:33Z","timestamp":1736435853000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1818087624000837"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S1818087624000837"],"URL":"https:\/\/doi.org\/10.1016\/j.ajps.2024.100966","relation":{},"ISSN":["1818-0876"],"issn-type":[{"value":"1818-0876","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structure based release kinetics analysis of doxazosin mesylate sustained-release tablets using micro-computed tomography","name":"articletitle","label":"Article Title"},{"value":"Asian Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajps.2024.100966","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Shenyang Pharmaceutical University. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100966"}}